Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2/3 SYR-322 add-on to metformin in type 2 diabetes
jRCT2080220606Phase 3
- Sponsor
- Takeda
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220606.